Abstract: I/O measurement data for channels attached to logical control unit queues is obtained related to a plurality of logical control unit queues. A store secondary queue measurement data instruction specifies a range of queues for which extended secondary measurement blocks derived from the I/O measurement data are stored at a memory address specified by the store secondary queue measurement data instruction.

Abstract: I/O measurement data associated with the performance of an I/O operation process is gathered during the I/O process. The I/O measurement data is saved in an IRB memory location specified by a test subchannel instruction. An I/O interrupt signals the completion of the I/O operation process.

Abstract: A method for separating a metal from a composition including the metal involves forming an electrolytic cell in which the anode comprises a composition including the metal. The electrolyte is an ionic liquid. A sufficient potential difference is applied between the anode and the cathode to cause the metal to transfer from the anode to the cathode deposited thereon.

Abstract: A combined PET/MRI scanner generally includes a magnet for producing a magnetic field suitable for magnetic resonance imaging, a radiofrequency (RF) coil disposed within the magnetic field produced by the magnet and a ring tomograph disposed within the magnetic field produced by the magnet. The ring tomograph includes a scintillator layer for outputting at least one photon in response to an annihilation event, a detection array coupled to the scintillator layer for detecting the at least one photon outputted by the scintillator layer and for outputting a detection signal in response to the detected photon and a front-end electronic array coupled to the detection array for receiving the detection signal, wherein the front-end array has a preamplifier and a shaper network for conditioning the detection signal.

Abstract: Disclosed is a system, method, and program for selecting one of multiple proposed paths to a device. For each proposed path, a determination is made of a number of components the proposed path shares with existing paths to the device. The components comprise points of failure such that if one component fails then the path including the component fails. The determined number of shared components for each proposed path is used to select one proposed path.

Abstract: Apparatus for regulating a driver, such as a single-shaft gas turbine, driving a gas compressor, such as a refrigerant compressor in a baseload LNG plant. The compressor has a gas inlet and a gas outlet and includes: a recycle pressure relief device in fluid communication with the gas outlet, the recycle pressure relief device adapted to receive a stream of a compressed gas having a discharge pressure from the gas outlet; and a conduit in fluid communication with the gas inlet, whereby the gas inlet receives at least a portion of the stream of the compressed gas transmitted to the conduit from the recycle pressure relief device when the discharge pressure reaches a designated pressure.

Abstract: A method of removing from a metal salt ionic species contained therein involves contacting the metal salt with an ionic liquid to dissolve the metal salt, the ionic species or both. At least in the case where both the metal salt and the ionic species are dissolved, the resultant ionic liquid composition is treated to separate the ionic species therefrom and subsequently processed to recover the metal salt.

Abstract: A canine-derived hemoglobin blood substitute comprising an extract of dog erythrocyte cytoplasm in a pharmaceutically acceptable carrier, the process for preparing the same and uses thereof. The process comprises utilizing membrane molecular phase transitions to induce and reverse a nonporous-porous behavior of erythrocytes, conserving all membrane and cytoskeletal material as well as all cytoplasmic enzymes including methemoglobin-reducing enzymes, yielding large quantities that do not require dialysis to remove potassium, and steps to easily prepare and use the product without extensive processing or chromatographic separation. In contrast to the prior art, the canine-derived blood substitute does not exhibit hypertension, vasoconstriction or loss of blood volume. The homologous product is intended for treatment of diseases or medical conditions of dogs requiring an increase, restoration or supplement in oxygen perfusion without hemodynamic or immunologic restriction.